Global:EN

CN EN
Company Profile

Rayzon was established in 2019 and has operations in Changsha, Beijing, Shanghai, Hong Kong, Germany, etc. We embrace the prin-ciples of patients first, professionalism and innovation. We are an international ophthalmic health technology company that incorpo-rates research and development, manufacture, commercialization, and service.


Rayzon closely collaborates with healthcare providers and research institutions worldwide, striving to develop products that better meet the needs of doctors and patients, and benefit everyone in the world. Through in-house research and development, investments, we have established a rich product line collaborations for optometry and ophthalmology.

Insightful
洞察探索

We believe it is patient needs that drive the development of medical products enterprises. Only with insights of patient needs can we carry out constant and successful innovation.

Self-Motivated
自主驱动

We are a medical technology enterprise integrates research and development, manufacture and commercialization. We believe the achievement of each strategic goal comes from diligent thinking and action, therefore we advocate a self-motivated culture.

People- First
以人为本

We listen to our patients, physicians, partners, with passion, and provide them with accessible solutions. We respect and care for each employee’s physical and mental health, quality of life and career development.

Focus & Enterprising
专注进取

We strive to be industry leader, dare to enter the unknown, and have the passion to consistently exceed ex-pectations. We focus on every detail of our products, every interaction with patients and doctors, and strive to challenge higher goals.

Key Milestones
2019

Rayzon Medical was established.

Our core business is promotion and sales of well- known ortho-keratology lenses and lens care solutions in China.

Established domestic R&D center

To develop myopia control prod-ucts for China patients. Set up surgical consumables business in Europe in the same year.
2020

Established domestic manufac-ture base

To development and manufacture of surgical prod-ucts.

Established material laboratory

To accelerate in-house development of materials.
2021

Incorporated raw material enter-prise in Europe

And strengthened R&D capability for raw materials.

The self-developed orthokera-tology lens entered clinical trial, accelerating business presence in domestic market.

2022

The self-developed scleral lens started

clinical trial to fill the gap in China market.

Continued to strengthen pipe-line through

overseas technolo-gy transfer.
2023

Launched Oculista defocus spec-tacle lenses.

Incorporated ophthalmic knives

into Rayzon product line.
2024

Launched Oculista rigid gas permeablecontact lenses for orthokeratology.

2025

Launched Oculista rigid scleral contactlens

2019

2020

2021

2022

2023

2024

2025

Corporate Culture

用创新激活无限睛彩


面对这个瞬息万变的时代

我们以挑战的姿势,严谨的态度力求突破

我们肩负使命

不止是改善视力,还原光明

更是予人在眼睛上更多的光彩

聆听患者,对每一个临床需求反复推敲

传承专业,积极探寻与集结世界的智慧方法

全力以赴,激活无限可能

我们跨越边界

打通从材料到产品的链路

凝结力量,超越预期设定,为心灵之窗的破茧喝彩

关爱社会,积极助力

以最敬畏的心和最尖端的科技

为眼健康事业提供完整解决方案

日趋于新,臻于至善

携手 看见 实现睛彩

Corporate Social Responsibility
Facing the international community, we hope to be the represent-ative of “quality” and “service” in the ophthal- mic industry. We extend the service cycle to “pre-diagnosis” and “post-operation”, disseminate knowledge about ophthalmic diseases and health care, and break the public’s fear and misunderstanding of diseases.
  • To Public

    We are a trusted ophthalmic brand.
  • To Patients And Eyecare Professionals

    We are eye health solution provider.
  • To Employees

    We respect, care for and develop our employees.
  • To Government

    We are an honest enterprise dedicated to helping pa-tients solve their ophthalmic problems.